Epigallocatechin-3-Gallate, an Active Green Tea Component to Support Anti-VEGFA Therapy in Wet Age-Related Macular Degeneration.
AMD
EGCG
VEGF
age-related macular degeneration
anti-VEGF therapy
autophagy
epigallocatechin-3-gallate
green tea
neovascularization
vascular endothelial growth factor
Journal
Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595
Informations de publication
Date de publication:
28 Jul 2023
28 Jul 2023
Historique:
received:
23
06
2023
revised:
19
07
2023
accepted:
27
07
2023
medline:
14
8
2023
pubmed:
12
8
2023
entrez:
12
8
2023
Statut:
epublish
Résumé
Age-related macular degeneration (AMD) is a largely incurable disease and an emerging problem in aging societies. It occurs in two forms, dry and wet (exudative, neovascular), which may cause legal blindness and sight loss. Currently, there is not any effective treatment for dry AMD. Meanwhile, repeated intravitreal injections with antibodies effective against vascular endothelial growth factor A (VEGFA) slow down wet AMD progression but are not free from complications. (-)-Epigallocatechin-3-gallate (EGCG) is an active compound of green tea, which exerts many beneficial effects in the retinal pigment epithelium and the neural retina. It has been reported to downregulate the
Identifiants
pubmed: 37571296
pii: nu15153358
doi: 10.3390/nu15153358
pmc: PMC10421466
pii:
doi:
Substances chimiques
Vascular Endothelial Growth Factor A
0
Tea
0
epigallocatechin gallate
BQM438CTEL
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Références
Microbiol Mol Biol Rev. 2011 Mar;75(1):50-83
pubmed: 21372320
Elife. 2016 Apr 07;5:e13876
pubmed: 27052508
N Engl J Med. 2006 Oct 5;355(14):1419-31
pubmed: 17021318
Expert Opin Ther Targets. 2022 Oct;26(10):883-895
pubmed: 36529978
Cell Growth Differ. 1996 Feb;7(2):213-21
pubmed: 8822205
Autophagy. 2023 Feb;19(2):388-400
pubmed: 35468037
Cells. 2022 Nov 01;11(21):
pubmed: 36359849
Neural Regen Res. 2022 Mar;17(3):625-631
pubmed: 34380903
Eye (Lond). 2014 Jan;28(1):93-101
pubmed: 24202050
Drug Des Devel Ther. 2016 Jun 02;10:1857-67
pubmed: 27330279
Cold Spring Harb Perspect Med. 2014 Oct 16;5(2):a017111
pubmed: 25324231
Eur J Clin Nutr. 2018 Jan;72(1):161-167
pubmed: 28952611
J Alzheimers Dis. 2020;77(1):411-421
pubmed: 32804140
Ther Adv Chronic Dis. 2012 Jul;3(4):153-61
pubmed: 23342231
Clin Ophthalmol. 2023 Mar 17;17:879-885
pubmed: 36960325
J Clin Med. 2021 Mar 02;10(5):
pubmed: 33801185
Physiology (Bethesda). 2006 Oct;21:362-9
pubmed: 16990457
J Cell Mol Med. 2007 Sep-Oct;11(5):1012-30
pubmed: 17979880
Mol Vis. 2008;14:2528-34
pubmed: 19119326
Biochemistry. 1997 Feb 25;36(8):2139-46
pubmed: 9047313
Prog Retin Eye Res. 2020 Nov;79:100858
pubmed: 32298788
Structure. 1997 Oct 15;5(10):1325-38
pubmed: 9351807
Eur J Pharmacol. 2023 Jun 15;949:175586
pubmed: 36906141
Eur J Pharmacol. 2004 Jan 12;483(2-3):223-7
pubmed: 14729110
Anticancer Res. 2020 Feb;40(2):677-688
pubmed: 32014908
Nucleic Acids Res. 2013 Sep;41(17):7997-8010
pubmed: 23851566
Graefes Arch Clin Exp Ophthalmol. 2021 Aug;259(8):2085-2093
pubmed: 33415353
Am J Epidemiol. 2009 Mar 1;169(5):633-41
pubmed: 19074778
Sci Rep. 2020 Dec 17;10(1):22122
pubmed: 33335269
J Intern Med. 2018 Jul;284(1):37-49
pubmed: 29706028
Nat Commun. 2023 Apr 26;14(1):2407
pubmed: 37100807
Ophthalmology. 2006 Sep;113(9):1508.e1-25
pubmed: 16828500
Oxid Med Cell Longev. 2018 Jan 31;2018:6721530
pubmed: 29636854
J Nutr. 2002 Aug;132(8):2307-11
pubmed: 12163680
Diabetes Metab Syndr. 2021 Jan-Feb;15(1):23-31
pubmed: 33285391
Br J Cancer. 2001 Mar 23;84(6):844-50
pubmed: 11259102
Food Funct. 2021 May 11;12(9):3799-3819
pubmed: 33977999
Front Med (Lausanne). 2021 Nov 11;8:735318
pubmed: 34859005
Prostate. 2023 Jul;83(10):929-935
pubmed: 37051922
Ophthalmology. 2009 Jan;116(1):57-65.e5
pubmed: 19118696
Int J Biol Macromol. 2019 Feb 1;122:95-103
pubmed: 30342140
J Cell Mol Med. 2019 Dec;23(12):8464-8471
pubmed: 31633290
Cochrane Database Syst Rev. 2020 May 5;5:CD012208
pubmed: 32374423
Am J Ophthalmol. 2021 Apr;224:228-237
pubmed: 33279454
Curr Opin Clin Nutr Metab Care. 2023 Jul 1;26(4):377-381
pubmed: 37057659
Expert Opin Drug Discov. 2018 Jul;13(7):643-660
pubmed: 29688074
Clin Exp Optom. 2007 Jul;90(4):263-71
pubmed: 17535365
Cancers (Basel). 2023 Sep 07;15(18):
pubmed: 37760436
Medicine (Baltimore). 2016 May;95(19):e3413
pubmed: 27175642
Int J Biol Macromol. 2018 May;111:780-786
pubmed: 29355627
Retina. 2014 Aug;34(8):1531-8
pubmed: 24637667
Science. 1983 Feb 25;219(4587):983-5
pubmed: 6823562
Cancers (Basel). 2021 Mar 08;13(5):
pubmed: 33800431
J Biophotonics. 2018 Jul;11(7):e201700377
pubmed: 29603665
Nucleic Acids Res. 2008 Apr;36(7):2434-45
pubmed: 18304943
J Nutr Biochem. 2015 Nov;26(11):1357-67
pubmed: 26362107
Semin Cancer Biol. 2023 Jul;92:130-138
pubmed: 37068553
Biochem Biophys Res Commun. 2013 Sep 6;438(4):739-45
pubmed: 23916613
Invest Ophthalmol Vis Sci. 1986 Nov;27(11):1644-52
pubmed: 2429937
Cell. 2014 Jun 19;157(7):1605-18
pubmed: 24949972
Comput Struct Biotechnol J. 2019 Oct 24;17:1326-1338
pubmed: 31741723
Oncotarget. 2015;6(12):9701-17
pubmed: 25991666
J Orthop Res. 2018 Sep;36(9):2476-2483
pubmed: 29663489
Eur J Clin Nutr. 2021 Jun;75(6):865-876
pubmed: 32820240
Graefes Arch Clin Exp Ophthalmol. 2009 Oct;247(10):1361-7
pubmed: 19590888
Genes Cancer. 2011 Dec;2(12):1097-105
pubmed: 22866201
Arch Ophthalmol. 2001 Oct;119(10):1417-36
pubmed: 11594942
J Food Biochem. 2022 Dec;46(12):e14487
pubmed: 36309930
Clin Ophthalmol. 2016 Feb 03;10:257-67
pubmed: 26893539
Nutrients. 2023 Mar 30;15(7):
pubmed: 37049514
Invest Ophthalmol Vis Sci. 2012 Dec 13;53(13):8146-53
pubmed: 23139279
PLoS One. 2016 May 20;11(5):e0153052
pubmed: 27203434
Am J Pathol. 2014 Apr;184(4):1230-1239
pubmed: 24630601
Biomed Pharmacother. 2020 Jan;121:109606
pubmed: 31743875
Proc Natl Acad Sci U S A. 1997 Jul 8;94(14):7192-7
pubmed: 9207067
Int J Cancer. 2003 Oct 10;106(6):871-8
pubmed: 12918064
Br J Ophthalmol. 2012 Jan;96(1):1-2
pubmed: 22157632
Int J Biol Macromol. 2018 Aug;115:600-607
pubmed: 29627466
Ophthalmology. 2014 May;121(5):1079-91
pubmed: 24433969
Cell Mol Life Sci. 2016 May;73(9):1765-86
pubmed: 26852158
Am J Clin Nutr. 2011 Dec;94(6):1697S-1702S
pubmed: 22089445
Exp Cell Res. 2019 Jul 15;380(2):149-158
pubmed: 30998948
Nutrition. 2018 Jul - Aug;51-52:6-12
pubmed: 29547735
Medicines (Basel). 2022 Mar 01;9(3):
pubmed: 35323719
Br J Haematol. 2005 Feb;128(3):303-9
pubmed: 15667531
Br J Ophthalmol. 2014 Sep;98(9):1144-67
pubmed: 25136079
PLoS One. 2011 Apr 22;6(4):e18921
pubmed: 21526120
Autophagy. 2021 Jan;17(1):1-382
pubmed: 33634751
Adv Cancer Res. 1995;67:281-316
pubmed: 8571818
Int J Mol Sci. 2021 Apr 14;22(8):
pubmed: 33919748
J Clin Invest. 2002 Apr;109(8):987-91
pubmed: 11956233
Curr Opin Ophthalmol. 2023 May 1;34(3):189-194
pubmed: 36866844
Sci Rep. 2021 Jan 26;11(1):2232
pubmed: 33500561
Front Cell Dev Biol. 2022 Sep 16;10:994037
pubmed: 36187470
Brain Res. 2006 Dec 8;1124(1):176-87
pubmed: 17084820
FASEB J. 2019 Jan;33(1):34-48
pubmed: 30085886
Ann Med. 2006;38(7):450-71
pubmed: 17101537
Front Med (Lausanne). 2020 Oct 07;7:579603
pubmed: 33117836
JAMA Ophthalmol. 2014 Feb;132(2):142-9
pubmed: 24310343
Nutr Metab Cardiovasc Dis. 2022 Sep;32(9):2026-2040
pubmed: 35750605
Expert Rev Clin Immunol. 2023 Apr;19(4):431-438
pubmed: 37051666
Diabet Med. 2013 Jun;30(6):640-50
pubmed: 23205608
Brain Res. 2007 Jul 23;1159:40-53
pubmed: 17573045
Mol Vis. 2010 Apr 03;16:586-95
pubmed: 20376327
Semin Cell Dev Biol. 2014 Dec;36:121-9
pubmed: 25158238
Arch Ophthalmol. 1997 Feb;115(2):237-41
pubmed: 9046259
Invest Ophthalmol Vis Sci. 2014 Oct 21;55(11):7619-27
pubmed: 25335979
Curr Oncol Rep. 2012 Aug;14(4):285-94
pubmed: 22544560
Eye (Lond). 2013 Jul;27(7):787-94
pubmed: 23722722
Adv Exp Med Biol. 2017;996:15-23
pubmed: 29124687
Cancer Lett. 2010 Jun 1;292(1):48-53
pubmed: 19962231
Mol Cell Biol. 2005 Jan;25(1):355-63
pubmed: 15601856
Nutr Rev. 2015 Jul;73(7):448-62
pubmed: 26081455
Retina. 2018 Oct;38(10):1937-1953
pubmed: 29746415